Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Functional gastrointestinal disorders (FGIDs) account for at least 40% of all referrals to gastroenterologists. Of the 33 recognized adult FGIDs, irritable bowel syndrome (IBS) is the most prevalent, with a worldwide prevalence estimated at 12%. IBS is an important health care concern as it greatly affects patients’ quality of life and imposes a significant economic burden to the health care system. Cardinal symptoms of IBS include abdominal pain and altered bowel habits. The absence of abdominal pain makes the diagnosis of IBS untenable. The diagnosis of IBS can be made by performing a careful review of the patient’s symptoms, taking a thoughtful history (e.g., diet, medication, medical, surgical, and psychological history), evaluating the patient for the presence of warning signs (e.g., “red flags” of anemia, hematochezia, unintentional weight loss, or a family history of colorectal cancer or inflammatory bowel disease), performing a guided physical examination, and using the Rome IV criteria. The Rome criteria were developed by a panel of international experts in the field of functional gastrointestinal disorders. Although initially developed to guide researchers, these criteria have undergone several revisions with the intent of making them clinically useful and relevant. This monograph provides a brief overview on the development of the Rome criteria, discusses the utility of the Rome IV criteria, and reviews how the criteria can be applied clinically to diagnose IBS. In addition, a diagnostic strategy for the cost-effective diagnosis of IBS will be reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the diagnostic criteria for functional somatic disorders usually do not require that the symptoms cause distress”
From Persistent physical symptoms: definition, genesis, and management (2024) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the Rome IV criteria for irritable bowel syndrome describe only clear patterns of abdominal pain and altered bowel habits”
From Persistent physical symptoms: definition, genesis, and management (2024) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244 · cited 3×
“Bristol stool types 1 and 2 or types 6 and 7 are considered abnormal [12].”
BackgroundMethodInfluentialLacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Self-citationFunctional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · cited 1×
“The revised Rome II criteria were published in 1999 [5].”
MethodTowards positive diagnosis of the irritable bowel.
Manning, A. P., Thompson, W. G., Heaton, K. W., & Morris, A. F. (1978) · BMJ · doi:10.1136/bmj.2.6138.653 · Cited by 1,374
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
Palsson, O. S., Whitehead, W. E., van Tilburg, M. A. L., Chang, L., Chey, W., Crowell, M. D., Keefer, L., Lembo, A. J., Parkman, H. P., Rao, S. S. C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.014 · Cited by 719
Ford, A. C., Lacy, B. E., & Talley, N. J. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1607547 · Cited by 587
Self-citationLagattolla, N. (2002) · Key Topics in General Surgery · doi:10.1201/b14719-46 · Cited by 521
Tibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I., & Bjarnason, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.34755 · Cited by 441 · cited 1×
“The diagnostic accuracy of the Rome I criteria was evaluated in a study of 339 IBS patients with a reported sensitivity of 85% and a specificity of 71% [4].”
MethodFord, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.148 · Cited by 405 · cited 1×
“This should improve visceral pain and may slow colonic transit to some degree [19].”
BackgroundSelf-citation
Cited by
Items 201–300 of 582
Wei, X., Wen, Y., Wei, Y., Xu, L., Ma, X., Zhang, B., & Tang, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.940328 · Cited by 9
“However, 40% of all cases are IBS-D (2, 3).”
BackgroundThe Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome
Morales, P. S., Wijeyesekera, A., Robertson, M. D., Jackson, P. P. J., & Gibson, G. R. (2022) · Microorganisms · doi:10.3390/microorganisms10122338 · Cited by 11
Körner, E., & Lorentz, A. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad044 · Cited by 10
Optimizing the treatment of patients with irritable bowel syndrome: focus on increased compliance
Андреев, Д. Н., & Dicheva, D. T. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-3-118-124 · Cited by 13
Alshaikh, A. A., Alamri, S. M., Riaz, F., Mahmood, S. E., Shlwan, M. A. M., Almuidh, F. N. A., Alshahrani, O. A. S., Asiri, M. A. M., Almuaddi, A. S. H., Qasim, N. Y. A., et al. (2024) · Medicine · doi:10.1097/md.0000000000038099 · Cited by 10
“[2] The prevalence of IBS varies from 5.7% to 34.0% worldwide, with a wide variation according to the diagnostic tool used.”
BackgroundInfluentialGao, Y., Borjihan, Q., Zhang, W., Li, L., Wang, D., Bai, L., Zhu, S., & Chen, Y. (2025) · Nutrients · doi:10.3390/nu17050801 · Cited by 9
Jafari, M., Sabahi, P., Jahan, F., & Asl, N. S. (2022) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc.122098 · Cited by 9
Saneie, S., Aminianfar, A., Shidfar, F., Keshteli, A. H., Esmaillzadeh, A., & Adibi, P. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02531-3 · Cited by 8
“In this study, subjects with hard or lumpy stools, or loose, mushy, or watery stools at least occasionally, were considered to have mixed IBS [49].”
BackgroundAbdelmalak, M. F. L., Abdelrahim, D. S., Michael, T. G., Abdel-Maksoud, O. M., & Labib, J. M. W. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3774 · Cited by 10
“lower abdominal pain and alternation in bowel habits according to ROME IV criteria.(1) It affects 1 in 10 people worldwide with a negative impact on their quality of life.”
MethodEffects of irritable bowel syndrome on the health-related quality of life among the Saudi population
Aljahdli, E. S., Badroun, F., Mushaeb, H. H., Aljohani, R., ALBISHER, S., Basalaim, L., & Baeisa, S. (2023) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_107_23 · Cited by 8
“[9] Patients with IBS experience higher rates of absenteeism, avoidance of social situations, and feel compelled to remain close to the bathroom, in addition to irritability, depression, reduced confidence, or anxiety.”
BackgroundUnderstanding the potential causes of gastrointestinal dysfunctions in multiple system atrophy
Craig, C. F., Finkelstein, D. I., McQuade, R. M., & Diwakarla, S. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106296 · Cited by 8
Exploring new subgroups for irritable bowel syndrome using a machine learning algorithm
Mousavi, E., Keshteli, A. H., Sehhati, M., Vaez, A., & Adibi, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-45605-2 · Cited by 11
Management of Irritable Bowel Syndrome: Physician‐Dietitian Collaboration
Ireton-Jones, C. S., & Weisberg, M. F. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10567 · Cited by 8
Alshahrani, A. (2020) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2020.118549 · Cited by 10
Comparison of Next-Generation Assays for Fecal Calprotectin vs the PhiCal Assay
Lin, L. Y.-C., Wyness, S. P., Jensen, R., Bird, J., Norgyal, T., Jensen, G., & Johnson, L. M. (2021) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqab114 · Cited by 8
Brodwall, A., & Brekke, M. (2021) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2021.2012347 · Cited by 9
Peng, L. H., Fang, J., Dai, N., Shen, X. Z., Yang, Y. L., Sun, J. P., & Yang, Y. S. (2022) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13081 · Cited by 12
“sified into four subtypes based on their symptomatology: constipationpredominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), mixed-type IBS (IBS-M) and IBS-unclassified (IBS-U).(4,7) In particular, the characteristics of IBS-C include straining during bowel movements (BM), hard or lumpy stool, reduced frequency of…”
BackgroundGao, Y., Li, C., Li, J., Duan, M., Li, X., Zhao, L., Wu, Y., & Gu, S. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1498540 · Cited by 9
Nybacka, S., Kinnander, A., Augustin, H., & Bärebring, L. (2024) · BMC Nutrition · doi:10.1186/s40795-024-00945-8 · Cited by 8
“The diagnosis of IBS is currently based on the Rome IV criteria, which require the absence of abnormal organic or biochemical features that can explain the symptoms [4].”
MethodZhou, J., Lamichhane, N., Xu, Z., Wang, J., Quynh, V. D., Huang, J., Gao, F., Zhao, M., Chen, Z., & Zhao, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314678 · Cited by 11
Vitamin D in Irritable Bowel Syndrome: Exploring Its Role in Symptom Relief and Pathophysiology
Aggeletopoulou, I., Geramoutsos, G., Pastras, P., & Triantos, C. K. (2025) · Nutrients · doi:10.3390/nu17061028 · Cited by 10
“Individuals who do meet the criteria for IBS experience more intense symptoms and present a higher prevalence of psychological comorbidities [11,12].”
Wu, Z. Y., Wang, Z., Chang, X., Chen, X., Ding, Q., Fu, R., Chong, C., Tang, J., & Huang, C. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf403 · Cited by 10
“Based on the predominant bowel movement pattern,IBS-C and IBS-D primarily differentiated by stool morphology during abnormal bowel movements (hard/clustered versus loose/watery) [37, 38].”
Tarbiah, N. I., Alkhattabi, N. A., Aldamen, S. A., Qutah, B. M., Al-Zahrani, M. H., & Tayeb, H. O. (2021) · Journal Of Biochemical Technology · doi:10.51847/b8qu0h2tmu · Cited by 7
Mobasheri, F., Shidfar, F., Aminianfar, A., Keshteli, A. H., Esmaillzadeh, A., & Adibi, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-23098-9 · Cited by 8
Gravina, A. G., Pellegrino, R., Romeo, M., Palladino, G., Cipullo, M., Iadanza, G., Olivieri, S., Zagaria, G., Mazzarella, C., Durante, T., et al. (2023) · Reviews on Recent Clinical Trials · doi:10.2174/1574887118666230508154027 · Cited by 11
Chojnacki, J., Popławski, T., Kaczka, A., Romanowska, N., Chojnacki, C. J., & Gąsiorowska, A. (2024) · Nutrients · doi:10.3390/nu16172981 · Cited by 8
“The Rome IV Criteria distinguish 21 functional diseases in adults [2,3].”
BackgroundKrynicka, P., Kaczmarczyk, M., Skonieczna‐Żydecka, K., Cembrowska-Lech, D., Podsiadło, K., Dąbkowski, K., Gaweł, K., Botke, N., Zawada, I., Ławniczak, M., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-024-03580-6 · Cited by 7
“In the current study we have shown a statistically no significant association between higher BMI and an increased risk of developing IBS and FD. Observations reported by Lacy and Patel [28], suggested that weight control may play a role in the prevention and treatment of DGBI disorders.”
Skonieczna‐Żydecka, K., Stachowska, E., Maciejewska, D., Ryterská, K., Palma, J., Czerwińska-Rogowska, M., Kaczmarczyk, M., Gudan, A., Mruk, H., Świniarska, B., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15102256 · Cited by 7
Alnoman, A., Badeghiesh, A. M., Baghlaf, H. A., & Dahan, M. H. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1903421 · Cited by 9
“change in appearance or form of the stool [1,2].”
BackgroundAcharya, K., Bhardwaj, V., Chuahan, I., Mushfiq, S., Bhatt, S. M., & Lamba, B. M. (2023) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1411 · Cited by 7
Effectiveness of Probiotics in Patients With Constipation: A Systematic Review and Meta-Analysis
Mora, N. G., & Jaramillo, A. P. (2024) · Cureus · doi:10.7759/cureus.52013 · Cited by 12
“This condition is described as a disorder not caused by organic, structural, infectious, or metabolic factors and based on symptoms [2].”
BackgroundPapaefthymiou, A., Doulberis, M., Kountouras, J., Kolokytha, C., Galanopoulos, M., Liatsos, C. N., Kyriakos, N., Giakoumis, M., Papadomichelakis, M., Pοlyzos, S. A., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001439 · Cited by 7
SEVERITY OF IRRITABLE BOWEL SYNDROME SYMPTOMS AND FODMAPS INTAKE IN UNIVERSITY STUDENTS
Aufieri, M. C., Morimoto, J. M., & Viebig, R. F. (2021) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202100000-84 · Cited by 10
Abdellah, S. A., Scanzi, J., Gal, C., Martin, M., Beck, M., & Ojetti, V. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247446 · Cited by 8
“The cohort of patients consisted of male and female adults aged ≥18 years suffering from IBS according to Rome IV criteria [36] irrespective of subtype.”
MethodMicrobiota–Host Interactions: Exploring Their Dynamics and Contributions to Human Diseases
Chin, S. W., Low, Z. Y., Tan, W. Q., & Azman, A. S. (2025) · MicrobiologyOpen · doi:10.1002/mbo3.70043 · Cited by 7
Roy, Y. J., Mirani, Y., Raju, J., Ali, A. H. M., Gigi, A. A., Fawunmi, A., & Kombara, J. S. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2025.0184 · Cited by 7
Relationship of migraine and other forms of chronic pain
Ray, J. C., Matharu, M. S., & Hutton, E. J. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823357-3.00027-6 · Cited by 9
Spasmolytic Activity and Anti-Inflammatory Effect of Novel Mebeverine Derivatives
Stoyanova, M., Milusheva, M., Gledacheva, V., Stefanova, I. D., Todorova, M. M., Kircheva, N., Angelova, S., Pencheva, M. M., Stojnova, K., Tsoneva, S. H., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12102321 · Cited by 8
“There is still no gold standard for diagnosing IBS, despite the development of numerous diagnostic criteria, such as Manning, Kruis, and Rome I–IV [11–13].”
BackgroundDegovtsov, E. N., Трухан, Д. И., Nikonenko, V. A., & Kosenok, V. K. (2020) · Ambulatornaya khirurgiya = Ambulatory Surgery (Russia) · doi:10.21518/1995-1477-2020-1-2-46-56 · Cited by 6
Hsu, S.-M., Lin, H. ‐., Lin, M. ‐., & Huang, S. ‐. (2020) · Colorectal Disease · doi:10.1111/codi.15325 · Cited by 9
Screening for Celiac Disease in Patients with Irritable Bowel Syndrome Fulfilling Rome III Criteria
Al-Abachi, K. T. (2021) · Journal of Coloproctology · doi:10.1055/s-0041-1736645 · Cited by 6
Gollifer, R. M., Taylor, S. A., Menys, A., Zárate-López, N., Chatoor, D. R., Emmanuel, A. V., & Atkinson, D. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14381 · Cited by 5
Selvi, K. (2022) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.14744/dajpns.2022.00167 · Cited by 7
“For these reasons, in further studies, as suggested by Lacy and Patel (63), it is strongly recommended to include medical history, physical examination, and measurement of IBS’s warning signs (e.”
BackgroundGI factors, potential to predict prostate motion during radiotherapy; a scoping review
Alexander, S. E., Oelfke, U., McNair, H. A., & Tree, A. C. (2023) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2023.100604 · Cited by 6
“The Bristol Stool scale offers a more convenient way for patients to describe their bowel habits [170] and coupled with medical history this can guide further GI investigations as needed.”
BackgroundAssessment of Public’s Awareness Regarding Irritable Bowel Syndrome in Aseer Region, Saudi Arabia
Bawahab, M. A., Bhat, M. J., Asiri, F. N. M., Alshahrani, K., Alshehri, A. M., Almutairi, B. A. B., Alhumaidi, M. M., & Eskandar, R. M. (2023) · Healthcare · doi:10.3390/healthcare11081084 · Cited by 6
“Most community health providers believe that IBS is a diagnosis of exclusion; however, the guidelines emphasize that IBS is not a diagnosis of exclusion, and they encourage clinicians to make a positive diagnosis using the Rome criteria alone [5,6].”
MethodAbdominal massage and laxative use for constipation: a pilot study
Artale, S., Terzoni, S., Destrebecq, A. L. L., Sansone, C. M., Vitale, M. T., Sala, E., & Ferrara, P. (2023) · British Journal of Nursing · doi:10.12968/bjon.2023.32.14.666 · Cited by 6
AbdelQadir, Y. H., Nabhan, A. I., Althawadi, Y. J., Belal, M. M., Feiter, Y. Y., Madian, M. S., Omran, H. A. M., AbdelAzim, A. A., Abdelghafar, Y. A., & Nashwan, A. J. (2023) · Gastroenterology & Endoscopy · doi:10.1016/j.gande.2023.11.001 · Cited by 6
Alhazmi, A., Darraj, H., Abdali, H., Hakami, S. M., Alatiyyah, A., Dalak, M., Hakami, K., Ghalibi, A., Abdulwali, H. M., Jali, A., et al. (2024) · Cureus · doi:10.7759/cureus.53549 · Cited by 7
“In addition, the abdominal pain is not necessarily relieved by defecation; it may remain the same or even increase after defecation [9].”
BackgroundThe Irritable Bowel Syndrome (IBS): Understanding its types, prevalence, and treatment options
Porwal, A. D., Bhagwat, G. B., Sawarkar, J., & Kamble, P. P. (2024) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2024.22.1.1130 · Cited by 13
“The development of different subtypes highlights the complexity of the condition, requiring specialised treatment plans that cater to the particular requirements of each patient [27,28].”
Zeid, W. A., Ezzeldeen, E., Khattab, M. S., Ahmed, S. A., & Abdo, M. (2020) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.21608/aimj.2020.32333.1254 · Cited by 7
“1, 2 IBS is diagnosed clinically using the Rome IV criteria after excluding any warning signs, without the need for any biochemical markers.(3) Worldwide, IBS affects around 10%–25% of the population, which can burden any health care system and impair patients' quality of life.”
BackgroundMethodMitselou, A., Grammeniatis, V., Varouktsi, A., Papadatos, S. S., Klaroudas, A., Katsanos, K. H., & Galani, V. (2021) · Advanced Biomedical Research · doi:10.4103/abr.abr_2_20 · Cited by 6
“IBS patients fulfilled the Rome IV criteria.[11] Five cases were IBS‐D, mean age of 44 years (range: 19–61); nine cases were IBS‐C, mean age of 54 years (range: 22–66); and three cases were IBS‐A, mean age of 43 years (range: 40–52).”
MethodPalma, J., Antoniewicz, J., Borecki, K., Tejchman, K., Skonieczna‐Żydecka, K., Maciejewska, D., Ryterská, K., Komorniak, N., Czerwińska-Rogowska, M., Wolska, A., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111464 · Cited by 8
Taneva, I., Grumann, D., Schmidt, D., Taneva, E., von Arnim, U., Ansorge, T., & Wex, T. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02244-7 · Cited by 9
“IBS-related Rome criteria [34] was performed.”
Liu, Z., Zheng, Z., Wang, T., Liu, Z., & Zuo, Z. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad076 · Cited by 6
Fang, X., Wang, X., Zheng, W., Yin, Y., & Ge, X. (2025) · International Journal of Behavioral Medicine · doi:10.1007/s12529-025-10348-z · Cited by 5
“Studies met the following criteria to be considered for inclusion in this review: Population: Patients with IBS meet the diagnostic criteria, including Western medicine [27–29], Chinese medicine diagnostic criteria, or expert opinions [30].”
Chojnacki, M., Błońska, A., Kaczka, A., Chojnacki, J., Walecka‐Kapica, E., Romanowska, N., Przybyłowska-Sygut, K., & Popławski, T. (2025) · Nutrients · doi:10.3390/nu17132232 · Cited by 6
“Based on symptom presentation and the Rome IV criteria [34,35], all participants were diagnosed with unclassified irritable bowel syndrome (IBS-U).”
Khalil, T. A., Filmban, D. M., Sinnah, H. N. M., Fallatah, R. A., Sayis, A. A., Alruwaili, S. S., Alghamdi, S. A., Almutairi, N. F. M., Haider, A. M., Ajam, R. A., et al. (2023) · Cureus · doi:10.7759/cureus.49460 · Cited by 7
Leite, G., Rezaie, A. R., Morales, W., Weitsman, S. R., Germano, J. D. F., Barlow, G. M., Parodi, G., Pimentel, M. L., Villanueva-Millán, M. J., Sanchez, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69162-4 · Cited by 5
“In the past, IBS was principally diagnosed based on a constellation of symptoms in the absence of red flags and other conditions 21,22 .”
BackgroundMacintosh, A., Heenan, P. E., Wright‐McNaughton, M., Frampton, C. M., Skidmore, P. M. L., Wall, C. L., Muir, J. G., Talley, N. J., Roy, N. C., & Gearry, R. B. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1060928 · Cited by 6
“Swelling N (%) 67 (9) 62 (13) 42 (9) 8 (4) 4 (1) 31 (2)”
BackgroundSarhan, R. S. R., Marei, Y. M., & Marei, Y. M. (2023) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-023-00263-8 · Cited by 5
Mohammed, C., Fuego, J. P., Garcia, K. V., Jamil, H., Rajesh, R. Y., Escobar, A. S., Hassan, M. J., & Rai, M. (2024) · Cureus · doi:10.7759/cureus.57055 · Cited by 9
“Image Credits: Created With BioRender.com Dietary changes, lifestyle changes, and pharmaceutical interventions such as 5-HT3 antagonists, opioid agonists, antibiotics, and bile salt sequestrants are currently accessible therapies for IBS-D [8].”
BackgroundJiang, Y., liu, R., Tang, J. H., Li, M., Zhang, D., Pei, Z., Fan, S., Xu, R., Huang, H., & Lin, J. (2024) · Phytotherapy Research · doi:10.1002/ptr.8218 · Cited by 6
“Subtypes of IBS can be classified based on stool characteristics, including constipation type, diarrhea type, mixed type, and uncertain type (Lacy & Patel, 2017).”
Efficacy of Amitriptyline in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis
Iqbal, M., Hira, S., Saeed, H., Shahid, S., Butt, S. T., Rashid, K., Ahmad, M. K., Hussain, H. A., Mughal, A., Costa, G. P. A., et al. (2025) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm24084 · Cited by 8
Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome
Kirk, D., Louca, P., Attaye, I., Zhang, X., Wong, K. E., Michelotti, G. A., Falchi, M., Valdes, A. M., Williams, F. M. K., & Menni, C. (2025) · Metabolites · doi:10.3390/metabo15020121 · Cited by 7
“Diagnosis of IBS is based on the Rome III or Rome IV criteria, which focus on the frequency of abdominal pain or discomfort and associated changes in stool frequency or consistency within a defined timeframe [6].”
Safwat, E., Salah, M. M., & Hussein, H. A. (2020) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2020.08.003 · Cited by 6
Somvanapanich, P., Pitisuttithum, P., Sirimongkolkasem, J., Rattanachaisit, P., Jangsirikul, S., Patcharatrakul, T., & Gonlachanvit, S. (2023) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22214 · Cited by 8
“The number of high FODMAPs diet items in both IBS and non-IBS subgroups significantly decreased from baseline and was not different between groups (IBS patients: 11 [7-14] items to 5 [3-8] items; non-IBS patients: 10 [6-15] items to 5 [4-7] items; both P < 0.05).”
InfluentialAghamohammadi, V., Moghadam, H. R., Najafi, E., Nasiri, K., Hamidi, H., Hajizadeh, M., Zamani, P., Yagin, N. L., Bazyar, H., & Najafipour, F. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1545033 · Cited by 4
Current Landscape of Novel Therapeutic Agents and Drug Targets in Irritable Bowel Syndrome
Joshi, D. C., Raina, N., Joshi, N., Gurow, K., Gwasakoti, J., Sood, A., Mehrotra, A., Tuli, H. S., Paudel, K. R., & Gupta, M. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70133 · Cited by 4
Bogdanowska-Charkiewicz, D., Górski, P., Jurkowska, G., Środa, R., Swidnicka-Siergiejko, A. K., Dâbrowski, A., & Daniluk, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1725524 · Cited by 4
“…define IBS as the presence of abdominal pain occurring at least 1 day a week for the past 3 months, which is associated with at least two of the following symptoms: change in bowel movement frequency, change in stool consistency, and relief or worsening of pain in relation to bowel movements (10).”
From Gut Feeling to Gray Matter: Mapping Defecation Urgency in Irritable Bowel Syndrome
Barazanji, N., Sjödahl, J., Orell, G., Evripidou, M., Adjeiwaah, M., Icenhour, A., Lundberg, P., & Walter, S. (2026) · Gastroenterology · doi:10.1053/j.gastro.2026.01.032 · Cited by 5
H19 and TUG1 lncRNAs as Novel Biomarkers for Irritable Bowel Syndrome in Diabetic Patients
Esawy, M. M., Al‐Sowayan, N. S., Mobasher, M. A., Abd-elhameed, A., elbaser, E. S. A., Baioumy, S. A., & Shabana, M. A. (2022) · Biomedicines · doi:10.3390/biomedicines10112978 · Cited by 3
den Abbeele, P. V., Poppe, J., Baudot, A., & Vu, L. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199388 · Cited by 4
“Key symptoms of IBS are abdominal pain or discomfort and altered bowel habits, i.e., diarrhea (IBS-D), constipation (IBS-C) or a mix thereof (IBS-M) [9].”
Psychosomatic Disorders, Epigenome, and Gut Microbiota
Abdolmaleky, H. M., Pirani, A., & Pettinato, G. (2025) · Cells · doi:10.3390/cells14241959 · Cited by 6
“Psychosomatic disorders involve a link between mind and body in which changes in mental states influence physical health and performance and impair quality of life [2,3].”
Common Urinary and Bowel Disorders in the Geriatric Population
Manuelyan, Z., Muñiz, K. S., & Stein, E. M. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.06.009 · Cited by 6
Patch Test–Directed Dietary Avoidance in the Management of Irritable Bowel Syndrome
Stierstorfer, M., & Toro, B. (2021) · Cutis · doi:10.12788/cutis.0321 · Cited by 3
Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders
Alkhowaiter, S. S., Alshahrani, A. A., Almarzouqi, H. F., Alonazi, G. K., Alhawassi, T. M., & Al-Rasheed, M. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1131354 · Cited by 4
Abdel‐Qader, D. H. (2024) · National Journal of Community Medicine · doi:10.55489/njcm.150220243630 · Cited by 5
Torres-Maravilla, E., Carvalho, F. A., Holowacz, S., Delannoy, J., Lenoir, L., Jacouton, E., Barbut, F., Langella, P., Bermúdez‐Humarán, L. G., & Waligora‐Dupriet, A. (2024) · Beneficial Microbes · doi:10.1163/18762891-bja00006 · Cited by 6
Kader, L., Willits, A., Meriano, S., Christianson, J. A., La, J., Feng, B., Knight, B. E., Kosova, G., DeBerry, J. J., Coates, M. D., et al. (2024) · Journal of Pain · doi:10.1016/j.jpain.2024.104572 · Cited by 4
“A 2 (Active vs Inactive) × 2 (Pain vs No Pain) ANOVA confirmed a main effect of pain status (F [1, 24] = 6.935, P .05) but not disease status.”
InfluentialMahyoub, M. A., Abbas, O., Elhoumed, M., Ghabisha, S. A., Refat, M., Abbas, M. A., Al-Qurmoti, S., Li, Y., Ren, M., & He, S. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03320-w · Cited by 10
“Un-subtyped or unknown IBS (IBS-U) was used to describe cases where stool consistency did not consistently align with the patterns of IBS-C, IBS-D, or IBS-M, indicating a lack of sufficient deviation in stool consistency to meet the criteria of these subtypes [16].”
MethodBhagavathula, A. S., Qady, A. M. A., & Aldhaleei, W. A. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i23.106836 · Cited by 7
Sherwin, L. B., Deroche, C. B., Yevu-Johnson, J., Matteson, M., Bechtold, M., Jahnke, I., & Alexander, G. L. (2021) · CIN Computers Informatics Nursing · doi:10.1097/cin.0000000000000747 · Cited by 7
“The criteria for IBS diagnosis include that the patient experiences recurrent abdominal pain on average at least 1 day per week for the last 3 months and experience at least two or more of the following; pain is related to defecation, pain is associated with a change in the frequency and the form (appearance) of the s…”
BackgroundMethodGwakhyangjeonggi-san for irritable bowel syndrome
Park, J., Ko, S., Han, G., Kim, K., Jun, H., & Park, J.-W. (2021) · Medicine · doi:10.1097/md.0000000000026635 · Cited by 4
Syndrome de l’intestin irritable: Rôle du microbiote intestinal
Lajoie, F., Rousseau, G., Blanquet‐Diot, S., & Etienne‐Mesmin, L. (2021) · médecine/sciences · doi:10.1051/medsci/2021095 · Cited by 7
Shammari, S. A. A., Almogren, R., Alnofaie, M. F., Shammari, R. T. A., Alfirm, R., & Julaidan, G. (2022) · Medical Science · doi:10.54905/disssi/v26i121/ms76e1987 · Cited by 4
Triptolide attenuates irritable bowel syndrome via inhibiting ODC1
Ning, Z. H., Zhu, L., Zhang, X., Huang, C., Xiang, W., & Huang, B. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02847-8 · Cited by 8
“In line with the clinical pathology of IBS [34, 35], the pathological manifestations were not observed in the ileum and colon.”
BackgroundMujamammi, A. H., Al‐Hamdan, R., Sabi, E. M., Aldosari, Z. A., Shadid, A. M., Shadid, A. M., Alagla, S., Humaid, H. S., Abozaid, T. S., & Azzam, N. A. (2023) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2023.22490 · Cited by 4
Smirnova, G. I., Labinov, V., & Коrsunskiy, A. A. (2024) · Russian Pediatric Journal · doi:10.46563/1560-9561-2024-27-1-49-54 · Cited by 4
Azimi, M., Shahrbabaki, H. K. D., Raeiszadeh, M., & Eslami, O. (2024) · EXPLORE · doi:10.1016/j.explore.2024.05.011 · Cited by 6
2-Amino-N-Phenethylbenzamides for Irritable Bowel Syndrome Treatment
Milusheva, M., Stoyanova, M., Gledacheva, V., Stefanova, I. D., Todorova, M. M., Pencheva, M. M., Stojnova, K., Tsoneva, S. H., Nedialkov, P. T., & Nikolova, S. (2024) · Molecules · doi:10.3390/molecules29143375 · Cited by 4
“Despite the establishment of multiple diagnostic criteria over time, there is no gold standard for the diagnosis of IBS [3–6].”
BackgroundPalombo, G., Merone, M., Altomare, A., Gori, M., Terradura, C., Bacco, L., CHIERICO, F. D., Putignani, L., Cicala, M., Guarino, M. P. L., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105869 · Cited by 6
Parental Response to Only Children: Breaking the Stereotypes
Levy, R. L., Murphy, T., Kamp, K., Langer, S. L., & van Tilburg, M. A. L. (2021) · Children · doi:10.3390/children8070605 · Cited by 5
“Trained telephone interviewers conducted further screening to ensure the mother met the Rome criteria for IBS (the Rome criteria are the current worldwide accepted symptom-based diagnostic criteria for IBS) [38].”
MethodSun, H., Li, X., Chen, W., Jia, F., Su, J., Zhang, B., Wu, X., & Wu, P. (2021) · PubMed Central · Cited by 7
Lee, J. H., Sung, W.-S., Kim, E., & Kim, Y. W. (2021) · Medicine · doi:10.1097/md.0000000000024019 · Cited by 6
“The Rome criteria is the most widely used criteria for functional gastrointestinal disorders due to its reliable diagnostic accuracy, practicability, and specified IBS subtypes.([26]) According to the Rome criteria IV, IBS could be diagnosed if the criteria below are fulfilled for the last 3 months with symptom onset…”
MethodResearch Progress on Gut Microbiota in the Treatment of Irritable Bowel Syndrome
王, 思. (2024) · Traditional Chinese Medicine · doi:10.12677/tcm.2024.131002 · Cited by 4
Nutritional considerations in older adults
Brook, S. (2018) · British Journal of Community Nursing · doi:10.12968/bjcn.2018.23.9.449 · Cited by 4
Periodic Changes in the Gut Microbiome in Women with the Mixed Type of Irritable Bowel Syndrome
Kaczka, A., Błońska, A., Chojnacki, C. J., Gąsiorowska, A., Błasiak, J., Popławski, T., & Chojnacki, J. (2025) · Biomedicines · doi:10.3390/biomedicines13030652 · Cited by 3
“The diagnosis was consistent with the Rome IV Criteria [1], and the duration of the disease was from 3 to 8 years.”
Reyes-Diaz, S. A., Priego-Parra, B. A., Alvarez, H. R. O., Núñez-Jiménez, E. L., Dorantes-Nava, C. L., la Tijera, F. H., Amieva‐Balmori, M., Vélez, C. D., & Remes-Troche, J. M. (2025) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000883 · Cited by 4
“Individuals with IBS were eligible if they met the Rome IV Criteria for IBS and exhibited no alarm signs, such as anemia, weight loss, or fever (14).”
van den Belt, M., Liu, Z., Duijghuijsen, L. J., Zoetendal, E. G., Witteman, B. J. M., de Roos, N. M., Vos, A. P., Smidt, H., & de Wit, N. J. W. (2025) · Journal of Nutritional Science · doi:10.1017/jns.2025.10021 · Cited by 4
Kilpatrick, L. A., Chang, L., Labus, J. S., Shin, A., Choy, M., Dong, T. S., Naliboff, B. D., Mayer, E. A., & Church, A. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00739-y · Cited by 3
“Irritable bowel syndrome (IBS) is a female-predomi-nant disorder of gut–brain interactions, characterized by abdominal pain and alterations in stool form and/or frequency [1].”
Metadata
- Authors
- Lacy, B., & Patel, N.
- Affiliations
- Dartmouth–Hitchcock Medical Center (US)
- Corresponding author
- Patel, Nihal
- ORCID
- Lacy, Brian
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2017-10-26
- Volume
- 6
- Issue
- 11
- Pages
- 99
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC5704116
- OpenAlex
- W2766963630
- Semantic Scholar
- b33dc825c1d24803a560443b65c3158fbf3991dd
- Cited by
- 575
- References
- 22
- Citations by year
- 2026: 46 · 2025: 72 · 2024: 85 · 2023: 104 · 2022: 74 · 2021: 79 · 2020: 58 · 2019: 43 · 2018: 14
- FWCI
- 33.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- irritable bowel syndrome, Rome IV criteria, functional gastrointestinal disorders, IBS diagnosis, diagnostic criteria, abdominal pain, altered bowel habits, red flags, clinical history taking, cost-effective diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.